Xenoestrogen exposure and mechanisms of endocrine disruption

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Singleton, David W ^a   Khan, Sohaib A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Endocrine Disruptor; Estrogen Receptor; Mechanism; Phytoestrogen; Review; Xenoestrogen

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CHLORPHENOTANE; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; PESTICIDE; PHYTOESTROGEN; POLYCHLORINATED BIPHENYL; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; XENOESTROGEN; ESTROGEN; FUNGAL PROTEIN; VEGETABLE PROTEIN;

CANCER RISK; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENCY; ENDOCRINE DISEASE; ENDOCRINE DISRUPTION; ENZYME ACTIVATION; HUMAN; IN VIVO CULTURE; MOLECULAR MECHANICS; NERVOUS SYSTEM; NONHUMAN; REPRODUCTION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SIGNAL TRANSDUCTION; TOXICOLOGY; TUMOR; ANIMAL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; UROGENITAL SYSTEM;

FUNGI;

ANIMALS; ESTROGENS, NON-STEROIDAL; FUNGAL PROTEINS; HUMANS; NERVOUS SYSTEM; PLANT PROTEINS; UROGENITAL SYSTEM;

EID: 3142757383     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1010     Document Type: Review

References (96)

1. Cooper RL, Kavlock RJ: Endocrine disruptors and reproductive development: a weight-of-evidence overview. J Endocrinol 152, 159-66.(1997)
2. Guillette LJ, Jr., Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR: Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 102, 680-8.(1994)
3. Hogan MD, Newbold RR, McLachlan JA. Extrapolation of teratogenic reponses observed in laboratory animals to humans: DES as an illustrative example. In: Banbury Report 26: Developmental Toxicology: Mechanisms and Risk.:Cold Spring Harbor Laboratory, 1987;257-269.
4. Kavlock RJ: Overview of endocrine disruptor research activity in the United States. Chemosphere 39, 1227-36.(1999)
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al.: The nuclear receptor superfamily: the second decade. Cell 83, 835-9.(1995)
6. Klinge CM: Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29, 2905-19.(2001)
7. Klinge CM: Estrogen receptor interaction with co-activators and co-repressors. Steroids 65, 227-51.(2000)
8. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Grenne G: Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230, 20-6(2000)
9. Gustafsson JA: Estrogen receptor beta - a new dimension in estrogen mechanism of action. J Endocrinol 163, 379-83.(1999)
10. Couse JF, Lindzey J, Grandien K, Gustafsson JA. Korach KS: Tissue distribution and quantitative analysis of estrogen receptor- alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138, 4613-21.(1997)
11. Mitchner NA, Garlick C, Ben-Jonathan N: Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland. Endocrinology 139, 3976-83.(1998)
12. Sar M, Welsch F: Differential expression of estrogen receptor-beta and estrogen receptor- alpha in the rat ovary. Endocrinology 140, 963-71.(1999)
13. Shughrue PJ, Lane MV, Scrimo PJ, Merchenthaler I: Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 63, 498-504.(1998)
14. Shughrue PJ, Komm B, Merchenthaler I: The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids 61, 678-81.(1996)
15. Hall JM, McDonnell DP: The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140, 5566-78.(1999)
16. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-70.(1997)
17. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-63.(1998)
18. Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, Saville B, Safe S: Differential interaction of the methoxychlor metabolite 2,2-bis-(p- hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology 140, 5746-53.(1999)
19. McDonnell DP: The Molecular Pharmacology of SERMs. Trends Endocrinol Metab 10, 301-311.(1999)
20. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y: Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17, 3006-12.(1997)
21. Tonetti DA, Jordan VC: The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer. J Steroid Biochem Mol Biol 62, 119-28.(1997)
22. Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA: Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology 139, 1082-92.(1998)
23. Maruyama K, Endoh H, Sasaki-Iwaoka H, Kanou H, Shimaya E, Hashimoto S, Kato S, Kawashima H: A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. Biochem Biophys Res Commun 246, 142-7.(1998)
24. Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S, O'Connell P, Allred DC: A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60, 4026-9.(2000)
25. Coleman KM, Smith CL: Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci 6, D1379-91.(2001)
26. Collins P, Webb C: Estrogen hits the surface. Nat Med 5, 1130-1.(1999)
27. Levin ER: Cellular Functions of the Plasma Membrane Estrogen Receptor. Trends Endocrinol Metab 10, 374-377.(1999)
28. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M: The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci U S A 91, 3602-7.(2000)
29. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19, 2455-63.(1999)
30. Razandi M, Pedram A, Levin ER: Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14, 1434-47.(2000)
31. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S: Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60, 321-7.(2000)
32. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA: Daidzein and genistein contents of vegetables. Br J Nutr 84, 717-25.(2000)
33. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A: Phyto-oestrogens: where are we now? Br J Nutr 79, 393-406.(1998)
34. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103 Suppl 7, 103-12.(1995)
35. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE: Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68, 1453S-1461S.(1998)
36. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, Speizer FE, Wolff MS: Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337, 1253-8.(1997)
37. Makela S, Hyder SM, Stancel GM. Environmental Estrogens. In: Estrogens and Antiestrogens; Hdbk Exp Pharmacol, vol 135/II (Oettel M, Schillinger E, eds). Berlin:Springer, 1999;613-663
38. Davidson NE: Environmental estrogens and breast cancer risk. Curr Opin Oncol 10, 475-8.(1998)
39. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N: Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103, 608-12.(1995)
40. Olea N, Pulgar R, Perez P, Olea-Serrano F, Rivas A, Novillo-Fertrell A, Pedraza V, Soto AM, Sonnenschein C: Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 104, 298-305.(1996)
41. Howe SR, Borodinsky L: Potential exposure to bisphenol A from food-contact use of polycarbonate resins. Food Addit Contam 15, 370-5.(1998)
42. Howe SR, Borodinsky L, Lyon RS: Potential exposure to bisphenol A from food-contact use of expoy coated cans. J Coat Technol 70, 69-74(1998)
43. Wingender RJ, Niketas P, Switcala CK: Development of methods for the determination of bisphenol A in food stimulants. J Coat Technol 70, 75-82(1998)
44. Knaak JB, Sullivan LJ: Metabolism of bisphenol A in the rat. Toxicol Appl Pharmacol 8, 175-84.(1966)
45. Clark LB, Rosen RT, Hartman TG: Determination of alkylphenol ethoxylates and their acetic acid derivatives in drinking water by particle beam liquid chromatography/mass spectometry. Intern J Environ Anal Chem 41, 167-180(1992)
46. Mueller S, Schlatter J: Oestrogenic potency of nonylphenol in vivo - a case study to evaluate the relevance of human non-occupational exposure. Pure Appl Chem 70, 1847-1853(1998)
47. Degen GH, Bolt HM: Endocrine disruptors: update on xenoestrogens. Int Arch Occup Environ Health 73, 433-41.(2000)
48. Certa H, Fedtke N, Wiegand HJ, Muller AM, Bolt HM: Toxicokinetics of p-tert-octylphenol in male Wistar rats. Arch Toxicol 71, 112-22(1996)
49. Upmeier A, Degen GH, Schuhmacher US, Certa H, Bolt HM: Toxicokinetics of p-tert-octylphenol in female DA/Han rats after single i.v. and oral application. Arch Toxicol 73, 217-22.(1999)
50. Singer PL: Occupational oligospermia. J Am Med Assoc 140, 1249(1949)
51. Safe SH: Endocrine disruptors and human health - is there a problem? An update. Environ Health Perspect 108, 487-93.(2000)
52. Chia SE: Endocrine disruptors and male reproductive function - a short review. Int J Androl 23, 45-6.(2000)
53. Bigsby RM, Caperell-Grant A, Madhukar BV: Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomized mice. Cancer Res 57, 865-9.(1997)
54. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ, Jr., McLachlan JA: Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272, 1489-92.(1996)
55. Arnold SF, McLachlan JA: Synergistic signals in the environment. Environ Health Perspect 104, 1020-3.(1996)
56. Arcaro KF, Gierthy JF: Estrogenic resonses of human breast cancer cells to combinations of hydroxylated PCBs, pesticicides, and 17beta-estradiol. Fundam Appl Toxicol 36, 295(1997)
57. Ramamoorthy K, Wang F, Chen IC, Norris JD, McDonnell DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS, Safe S: Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology 138, 1520-7.(1997)
58. Safe S: Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells and yeast-based estrogen receptor assays: No apparent synergism. Fundam Appl Toxicol 36, (1997)
59. Wiese TE, Lambright CR, Kelce WR: Lack of synergistic estrogen effects of dieldrin and endosulfan mixtures on MCF-7 and MVLN cells. Fundam Appl Toxicol 36, (1997)
60. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM: Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci U S A 96, 3999-4004.(1999)
61. Sheeler CQ, Dudley MW, Khan SA: Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. Environ Health Perspect 108, 97-103.(2000)
62. Routledge EJ, White R, Parker MG, Sumpter JP: Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem 275, 35986-93.(2000)
63. Matthews JB, Twomey K, Zacharewski TR: In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 14, 149-57.(2001)
64. Kester MH, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Bergman A, Safe SH, Kuiper GG, Schuur AG, Brouwer A, Visser TJ: Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141, 1897-900.(2000)
65. Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, Arosemena PJ, Kellis JT, Jr., Vickery LE: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147-53.(1993)
66. Brouwer A, Morse DC, Lans MC, Schuur AG, Murk AJ, Klasson-Wehler E, Bergman A, Visser TJ: Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health 14, 59-84.(1998)
67. Divi RL, Chang HC, Doerge DR: Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol 54, 1087-96.(1997)
68. Gray LE, Jr., Ostby J, Cooper RL, Kelce WR: The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol Ind Health 15, 37-47.(1999)
69. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM: Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375, 581-5.(1995)
70. Bigsby R, Chapin RE, Daston GP, Davis BJ, Gorski J, Gray LE, Howdeshell KL, Zoeller RT, vom Saal FS: Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect 107 Suppl 4, 613-8.(1999)
71. Newbold R: Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103 Suppl 7, 83-7.(1995)
72. Golden RJ, Noller KL, Titus-Ernstoff L, Kaufman RH, Mittendorf R, Stillman R, Reese EA: Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit Rev Toxicol 28, 109-227.(1998)
73. Sonnenschein C, Soto AM: An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65, 143-50.(1998)
74. Gray LE, Jr.: Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol Lett 102-103, 331-5.(1998)
75. Herbst AL: Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 48, 484-8.(1981)
76. Guillette LJ, Jr., Gross TS, Gross DA, Rooney AA, Percival HF: Gonadal steroidogenesis in vitro from juvenile alligators obtained from contaminated or control lakes. Environ Health Perspect 103 Suppl 4, 31-6.(1995)
77. Guillette LJ, Jr., Crain DA, Rooney AA, Pickford DB: Organization versus activation: the role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife. Environ Health Perspect 103 Suppl 7, 157-64.(1995)
78. Ekelund R, Bergman A, Granmo A, Bergren M: Bioaccumulation of 4-nonylphenol in marine animals, a reevaluation. Environmental Pollution 64, 107-120(1990)
79. Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP: Estrogenic effects of effluents from sewage treatment works. Chemistry and Ecology 4, 275-285(1994)
80. Sumpter JP: Feminized responses in fish to environmental estrogens. Toxicol Lett 82-83, 737-42.(1995)
81. Katsuda S, Yoshida M, Watanabe G, Taya K, Maekawa A: Irreversible effects of neonatal exposure to p-tert-octylphenol on the reproductive tract in female rats. Toxicol Appl Pharmacol 165, 217-26.(2000)
82. Christian M, Gillies G: Developing hypothalamic dopaminergic neurones as potential targets for environmental estrogens. J Endocrinol 160, R1-6.(1999)
83. Morrissey RE, George JD, Price CJ, Tyl RW, Marr MC, Kimmel CA: The developmental toxicity of bisphenol A in rats and mice. Fundam Appl Toxicol 8, 571-82.(1987)
84. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D: Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132, 2279-86.(1993)
85. Laessig SA, McCarthy MM, Silbergeld EK: Neurotoxic effects of endocrine disruptors. Curr Opin Neurol 12, 745-51.(1999)
86. Dohler KD: Influence of hormones and hormone antagonists on sexual differentiation of the brain. Arch Toxicol Suppl 20, 131-41(1998)
87. Meisel RL, Sachs BD. The physiology of male sexual behavior. In: The Physiology of Reproduction (Knobil E, Neill JD, eds). New York:Raven Press, 1994;3-106.
88. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S: Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 36, 357-78.(1998)
89. Price RH, Jr., Lorenzon N, Handa RJ: Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variant missing exon 4. Brain Res Mol Brain Res 80, 260-8.(2000)
90. Hileman SM, Handa RJ, Jackson GL: Distribution of estrogen receptor-beta messenger ribonucleic acid in the male sheep hypothalamus. Biol Reprod 60, 1279-84.(1999)
91. Asplund L, Svensson BG, Nilsson A, Eriksson LJ, Jansson B, Jensen S, Wideqvist U, Skerfving S: Polychlorinated biphenyls, 1,1,1-trichloro-2,2-bis(p- chlorophenyl)ethane (p,p′-DDT) and 1,1-dichloro-2,2-bis(p-chlorophenyl)- ethylene (p,p′-DDE) in human plasma related to fish consumption. Arch Environ Health 49, 477-86.(1994)
92. Bates MN, Hannah DJ, Buckland SJ, Taucher JA, van Maanen T: Chlorinated organic contaminants in breast milk of New Zealand women. Environ Health Perspect 102 Suppl 1, 211-7.(1994)
93. Chung YW, Clemens LG: Effects of perinatal exposure to polychlorinated biphenyls on development of female sexual behavior. Bull Environ Contam Toxicol 62, 664-70.(1999)
94. Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM: Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158, 141-53.(2001)
95. Rice DC: Behavioral impairment produced by low-level postnatal PCB exposure in monkeys. Environ Res 80, S113-S121.(1999)
96. Hany J, Lilienthal H, Roth-Harer A, Ostendorp G, Heinzow B, Winneke G: Behavioral effects following single and combined maternal exposure to PCB 77 (3,4,3′,4′-tetrachlorobiphenyl) and PCB 47 (2,4,2′,4′- tetrachlorobiphenyl) in rats. Neurotoxicol Teratol 21, 147-56.(1999)